🇺🇸 FDA
Patent

US 8778354

Compositions and methods for modulating RSV infection and immunity

granted A61KA61K38/00A61K39/00

Quick answer

US patent 8778354 (Compositions and methods for modulating RSV infection and immunity) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61K39/00, A61P, A61P31/12